Utama › Adenokarsinoma Esofagus › Pennsylvania › Pittsburgh
Kajian klinikal Adenokarsinoma Esofagus di Pittsburgh, PA
8 kajian untuk Adenokarsinoma Esofagus sedang mencari peserta di lokasi dalam dan sekitar Pittsburgh (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Mengambil pesertaFasa 2/3
- UPMC-Saint Margaret, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- dan 4 lagi
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Mengambil pesertaFasa 2/3
- UPMC Hillman Cancer Center, Pittsburgh
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Mengambil peserta
- University of Pittsburgh Medical Center, Pittsburgh
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Mengambil pesertaFasa 3
- Research Site, Pittsburgh
- Research Site, Pittsburgh
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- University of Pittsburg Medical Center _UPMC Hillman Cancer Center, Pittsburgh
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Mengambil pesertaFasa 2
- UPMC Hillman Cancer Center, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Mengambil pesertaFasa 2
- UPMC Hillman Cancer Center, Pittsburgh
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
Mengambil pesertaFasa 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Kajian Adenokarsinoma Esofagus di bandar lain
- New York City, NY18 kajian
- Boston, MA13 kajian
- Houston, TX12 kajian
- Nashville, TN11 kajian
- Arlington, VA11 kajian
- Durham, NC10 kajian
- Rochester, MN9 kajian
- Baldwin Park, CA9 kajian
- St. Louis, MO9 kajian
- Jacksonville, FL9 kajian
- Queens, NY9 kajian
- Los Angeles, CA9 kajian
Kajian lain di Pittsburgh
- Kanser Paru-paru Bukan Sel Kecil48 kajian
- Kanser (semua jenis)41 kajian
- Kanser Payudara39 kajian
- Kanser Kolorektal32 kajian
- Kanser Metastatik31 kajian
- Melanoma31 kajian
- Kanser Ovari30 kajian
- Kanser Endometrium23 kajian
- Kanser Prostat23 kajian
- Kanser Paru-paru23 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher22 kajian
- Strok22 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.